Form 4: Fulgent Genetics President & COO Sells Shares for Tax Obligations

Jian Xie, President and COO of Fulgent Genetics, Inc., reported the sale of 1,135 shares of common stock to cover tax withholding obligations related to vested restricted stock units.

Summary

• Jian Xie, President and COO of Fulgent Genetics, Inc. (FLGT), reported a transaction on June 2, 2025.
• He sold 1,135 shares of Fulgent Genetics common stock at a weighted-average price of $20.2908 per share.
• The sale was conducted to satisfy tax withholding obligations arising from the vesting of restricted stock units (RSUs) granted on February 28, 2022.
• Following the transaction, Mr. Xie directly beneficially owns 371,496 shares and indirectly owns 220,816 shares through The Hsieh Family Dynasty Trust.

Sentiment

Score: 5

Explanation: The sentiment is neutral as this is a routine, non-discretionary insider transaction for tax purposes, which is a common occurrence and does not reflect a change in the company's fundamentals or the executive's confidence.

Negatives

• The transaction involves an insider selling shares, which, while for tax purposes, is still a reduction in direct insider ownership.

Future Outlook

The document does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Management Comments

• "The shares were sold from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 28, 2022."
• "The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."

Industry Context

This Form 4 filing details a routine insider transaction for tax purposes and does not provide information relevant to broader industry trends or competitive dynamics within the genetics or healthcare sectors.

Related Party Transactions

• Jian Xie indirectly holds 220,816 shares through The Hsieh Family Dynasty Trust, dated January 27, 2010, where he serves on the investment committee. Mr. Xie disclaims any beneficial interest except with respect to any pecuniary interest therein.

Stakeholder Impact

• Shareholders: The sale of a small number of shares by an executive for tax purposes is generally not seen as a significant indicator of company performance or executive confidence, thus having minimal direct impact on shareholder perception.

Key Dates

Keywords

Fulgent Genetics, FLGT, Jian Xie, Insider Trading, Form 4, Stock Sale, Restricted Stock Units, Tax Withholding, Beneficial Ownership